The role of the TAPSE/sPAP ratio as a predictor of mortality in Pulmonary Arterial Hypertension : Its value for patient risk stratification

Hemodynamic
Written By Frédéric Caruso
 

A TAPSE/sPAP ratio <0.18 mm/mmHg predicts mortality in PAH.

The combination of the TAPSE/sPAP ratio with the ESC/ERS risk score improved risk stratification, and reclassification emphasizing the potential of ESC/ERS+TAPSE/sPAP as a valuable tool for risk assessment and clinical decision-making in PAH patients.

Integration of TAPSE/sPAP ratio with other scores (COMPERA and REVEAL Lite 2) also improved the risk stratification and reclassification of these risk scores.

 

Reference

Thanks to the authors.

Frédéric Caruso
Previous

Difficult Airway Society 2025 guidelines for management of unanticipated difficult tracheal intubation in adults
Next

Ten rules for optimizing ventilatory settings and targets in post-cardiac arrest patients